| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
193.10 |
| Sales(₹ Cr.) |
1,055.07 |
NP (₹ Cr.) |
240.92 |
| NP Var% |
-30.00 |
Div% |
755.00 |
| CPS(₹) |
30.10 |
EPS (₹) |
23.00 |
| Traded Value(₹ Lakhs) |
75.35 |
52 Week High |
1,879.00 |
| 52 Week Low |
987.00 |
Price BSE |
1,333.00 |
| Price NSE |
1,330.00 |
Market Capital (₹ Cr.) |
13,947.43 |
| P/C Ratio |
44.20 |
P/E Ratio |
57.90 |
| Price Vs.BV |
6.90 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
325.89 |
| NP(₹ Cr.) |
90.02 |
NP Var % |
-37.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
1,085.75 |
| OPM |
-5.27 |
NP |
328.71 |
| NP Var% |
-30.26 |
EPS |
23.03 |
| PE |
57.89 |
|
|